During clinical trials of new drugs pharmaceutical companies must be able to depend on strict adherence to therapy regimens. However, up to 50 percent of patients involved in clinical trials do not adhere to the prescribed dosage regimen, resulting in distorted outcomes such as insufficient drug efficacy or underestimated frequency of side effects and delayed time to market. To enhance therapy adherence in clinical trials, Schreiner MediPharm (Oberschleißheim, Germany) and AARDEX Group (Seraing, Belgium) offer an electronic solution for medication adherence monitoring enabling pharmaceutical companies to digitally monitor and manage medication intake of their trial participants.
The development of 5G, big data, IoT and artificial intelligence has driven innovation in the world and prompted displays and smart applications to continuously evolve, with the transportation sector also greatly influenced. AU Optronics Corp. (Hsinchu, Taiwan) has obtained around 7.7% shares of SINTRONES Technology Corp. from a major shareholder through block trading. By acquiring the shares and forging an alliance, the two parties hope to establish strategic partnership for the AIoV ecosystem and jointly develop comprehensive solutions for smart transportation and commercial vehicle networking platforms.
Ynvisible Interactive Inc. (Vancouver, Canada) announces its first customer collaboration to bring new temperature indication solutions to market with SpotSee, the global leader in shock, vibration and temperature monitoring through low-cost connectivity and data. Both companies are partners in the CHARISMA project, funded by the European Union, Horizon 2020 Marie Skłodowska-Curie Actions programme.
